Darbepoetin alfa biosimilar (Nichi-Iko Pharmaceutical/Aprogen)
阿法达贝泊汀生物类似药 (Nichi-Iko Pharmaceutical/Aprogen)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameDarbepoetin alfa biosimilar (Nichi-Iko Pharmaceutical/Aprogen)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAprogenNichi-Iko Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAprogenNichi-Iko Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A